Preterm Donor Human Milk Supplementation of Mother's Own Milk in VLBW Infants

Recruiting now · Not applicable

Conditions studied: Prematurity

In brief

This prospective randomized controlled trial aims to investigate whether feeding very low birth weight (VLBW) infants with Mother's own milk (MOM) supplemented with either preterm (PDM) or term donor milk (TDM), when MOM is insufficient, has a positive impact on infants' protein intake, growth and morbidity.

Key facts

Study ID

NCT05675397

Run by

National and Kapodistrian University of Athens

People needed

200

Starts

2022-12-01

Expected to finish

2027-12-01

Last updated by the study team

2023-01-09

Who can join

Age: 0 and older, up to 0. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• VLBW infants with birth weight <1500g born to mothers who agree to provide donor milk for the first three weeks of life (donor milk period) if their own milk quantity is insufficient

You may not qualify if…

• Congenital anomalies
• Chromosomal disorders
• Metabolic diseases
• Feeding with formula at any point during the first 3 weeks of life (donor milk period)

Where it is running

• Neonatal Intensive Care Unit, "Elena Venizelou" General and Maternal Hospital — Athens, Greece (enrolling)
• First Department of Pediatrics, National and Kapodistrian University of Athens — Athens, Greece

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.